Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-025619

Chief Operating Officer sold 390 shares at $2.41 ($940)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Keuer Thomas A Chief Operating Officer 2017-04-04 Sale −390 $2.41 $940 14,045 D
Open-market sales · 390 sh · avg $2.41 · $940
Loading xslF345X03/doc4.xml…